IFP Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.78K | Buy |
266
+249
| +1,465% | +$3.48K | ﹤0.01% | 3825 |
|
|
2026
Q1 | $160 | Buy |
17
+10
| +143% | +$110 | ﹤0.01% | 4655 |
|
|
2025
Q4 | $87 | Buy |
7
+3
| +75% | +$40 | ﹤0.01% | 4616 |
|
|
2025
Q3 | $57 | Buy |
+4
| New | +$55 | ﹤0.01% | 4643 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 4442 |
|
|
2025
Q1 | – | Sell |
-60
| Closed | -$1.41K | – | 3536 |
|
|
2024
Q4 | $2.09K | Buy |
+60
| New | +$1.31K | ﹤0.01% | 3088 |
|
|
2024
Q1 | – | Sell |
-50
| Closed | -$2.18K | – | 3177 |
|
|
2023
Q4 | $2.18K | Sell |
50
-71
| -59% | -$2.79K | ﹤0.01% | 2660 |
|
|
2023
Q3 | $4.62K | Buy |
121
+49
| +68% | +$2.06K | ﹤0.01% | 2539 |
|
|
2023
Q2 | $2.96K | Hold |
72
| – | – | ﹤0.01% | 2743 |
|
|
2023
Q1 | $4.61K | Sell |
72
-342
| -83% | -$19.3K | ﹤0.01% | 2600 |
|
|
2022
Q4 | $29K | Buy |
414
+143
| +53% | +$7.28K | ﹤0.01% | 2621 |
|
|
2022
Q3 | $23K | Buy |
271
+47
| +21% | +$2.41K | ﹤0.01% | 2955 |
|
|
2022
Q2 | $20K | Hold |
224
| – | – | ﹤0.01% | 2831 |
|
|
2022
Q1 | $20K | Buy |
224
+152
| +211% | +$10K | ﹤0.01% | 2831 |
|
|
2021
Q4 | $6K | Sell |
72
-72
| -50% | -$4.87K | ﹤0.01% | 2417 |
|
|
2021
Q3 | $11K | Hold |
144
| – | – | ﹤0.01% | 2235 |
|
|
2021
Q2 | $10K | Hold |
144
| – | – | ﹤0.01% | 2207 |
|
|
2021
Q1 | $10K | Sell |
144
-139
| -49% | -$9.42K | ﹤0.01% | 2139 |
|
|
2020
Q4 | $18K | Hold |
283
| – | – | ﹤0.01% | 1837 |
|
|
2020
Q3 | $14K | Hold |
283
| – | – | ﹤0.01% | 1778 |
|
|
2020
Q2 | $13K | Sell |
283
-29
| -9% | -$1.43K | ﹤0.01% | 1728 |
|
|
2020
Q1 | $13K | Buy |
312
+14
| +5% | +$735 | ﹤0.01% | 1665 |
|
|
2019
Q4 | $18K | Sell |
298
-21
| -7% | -$1.25K | ﹤0.01% | 1655 |
|
|
2019
Q3 | $19K | Buy |
+319
| New | +$19K | ﹤0.01% | 1783 |
|
|
2019
Q1 | – | Sell |
-270
| Closed | -$12K | – | 2829 |
|
|
2018
Q4 | $12K | Sell |
270
-147
| -35% | -$8.06K | ﹤0.01% | 2410 |
|
|
2018
Q3 | $27K | Sell |
417
-120
| -22% | -$7.46K | ﹤0.01% | 2281 |
|
|
2018
Q2 | $35K | Buy |
537
+138
| +35% | +$8.54K | ﹤0.01% | 2128 |
|
|
2018
Q1 | $19K | Hold |
399
| – | – | ﹤0.01% | 2411 |
|
|
2017
Q4 | $19K | Buy |
399
+69
| +21% | +$3.38K | ﹤0.01% | 2447 |
|
|
2017
Q3 | $17K | Buy |
330
+44
| +15% | +$2.26K | ﹤0.01% | 2706 |
|
|
2017
Q2 | $16K | Sell |
286
-14
| -5% | -$669 | ﹤0.01% | 2708 |
|
|
2017
Q1 | $13K | Buy |
300
+4
| +1% | +$171 | ﹤0.01% | 2770 |
|
|
2016
Q4 | $13K | Buy |
296
+12
| +4% | +$488 | ﹤0.01% | 2753 |
|
|
2016
Q3 | $12K | Buy |
284
+96
| +51% | +$4.02K | ﹤0.01% | 2710 |
|
|
2016
Q2 | $7K | Buy |
+188
| New | +$6.76K | ﹤0.01% | 2944 |
|
|
2016
Q1 | – | Sell |
-180
| Closed | -$6K | – | 2844 |
|
|
2015
Q4 | $6K | Buy |
+180
| New | +$5.63K | ﹤0.01% | 2860 |
|
Other funds holding IART
RCMNY
PCMI
IFP Advisors's IART Position: Q2 2026 in Review
IFP Advisors increased its Integra LifeSciences (IART) stake by 1,465% in Q2 2026, buying an estimated $3.48K and bringing the position to 266 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3825.
IFP Advisors first reported a position in IART in Q4 2015 and has held it in 35 quarters since. The position peaked at $35K in Q2 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- IFP Advisors held 266 shares of Integra LifeSciences worth $4.78K as of Q2 2026.
- IFP Advisors bought 249 Integra LifeSciences shares in Q2 2026, an estimated $3.48K.
- Integra LifeSciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3825 holding.
- IFP Advisors first reported a position in Integra LifeSciences in Q4 2015 and has held it in 35 quarters since.
- IFP Advisors's Integra LifeSciences position peaked at $35K in Q2 2018.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.